Successful trials will not only ensure the labor and material costs are kept to a minimum but will also ensure indirect costs associated with negative impact to brand are avoided.
The FDA and USDA-FSIS agree and are withdrawing the proposed rule to reconsider how best to approach general principles and food standards modernization.